Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of the following announcement, make no representation as to its accuracy or completeness, and disclaim any liability for any loss arising from reliance on any part of its content.

Consun Pharmaceutical Group Limited (“Consun Pharma”) published a notice on 5 March 2026 stating that its board of directors will meet on 26 March 2026. The meeting agenda includes reviewing and approving the audited consolidated financial statements for the year ended 31 December 2025, approving the draft announcement of those financial results, and considering the payment of a final dividend. The board will also discuss arrangements for the forthcoming annual general meeting and other related matters.

The company specified that the board’s decision, along with the audited financial statements, will be published in accordance with relevant regulatory requirements. The notice was issued under the name of Chairman An Meng, with its board consisting of executive, non-executive, and independent non-executive directors.